OK ... but what was the intent of your quoted words ...? Please don 't write anything what I did not write and / or suggest.
I will post (together with "overdue" Q2 analysis and Q3 forecast / projection) ... but it will be about the Co net profit, since net profit on per unit basis is a meaningless category .... since indirect costs are "fix", top of KOWA and Pharmákon interest do not depends on sales volume ...
Please, post the details of Sun Trust report and I will tell you if / where I disagree with them.
I do not mind how you would like to interpret it, but the fact is fact: - V under $60 exists - in more than 1 plan ... we will see Flounderguy's rate card on Tuesday, but he paid $50 in 2016 w/o coupon That's all what I said vs you said it won't be in case of win at ITC ...
Are you saying that unlawful activity is soo American? It's the way as everything should be done ... interesting mentality ... Again: Amarin did not request a block of EE- / rTG EPA / DHA / O3 as all, but for illegal activity ... anybody could use it in the future as a ingredient in a drug ...